# An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

> **NCT02451839** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 168 (actual)

## Conditions studied

- Crohn's Disease
- Rheumatoid Arthritis
- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02451839
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-06
- **Primary completion:** 2017-12-05
- **Final completion:** 2017-12-05
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2019-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02451839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02451839, "An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT02451839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*